News
Don't miss out on all the biggest upcoming 2026 movies.
Yescarta – a CD19-directed genetically modified autologous T-cell immunotherapy investigated in the ZUMA-1 trial – is the first chimeric antigen receptor (CAR) T-cell therapy recommended for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback